AAAAAA
Results:
1-8
|
Results: 8
Authors:
Haas, N
Roth, B
Garay, C
Yeslow, G
Entmacher, M
Weinstein, A
Rogatko, A
Babb, J
Minnitti, C
Flinker, D
Gillon, T
Hudes, G
Citation: N. Haas et al., Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer, UROLOGY, 58(1), 2001, pp. 59-64
Authors:
Vaishampayan, U
Glode, M
Du, W
Kraft, A
Hudes, G
Wright, J
Hussain, M
Citation: U. Vaishampayan et al., Phase II study of dolastalin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma (vol 6, pg 4205, 2000), CLIN CANC R, 6(12), 2000, pp. 4967-4967
Authors:
Vaishampayan, U
Glode, M
Du, W
Kraft, A
Hudes, G
Wright, J
Hussain, M
Citation: U. Vaishampayan et al., Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma, CLIN CANC R, 6(11), 2000, pp. 4205-4208
Authors:
Haas, NB
Manola, J
Hudes, G
Citrin, DL
Kies, MS
Davis, TE
Citation: Nb. Haas et al., Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer - Eastern Cooperative OncologyGroup study PH882, AM J CL ONC, 23(6), 2000, pp. 589-592
Authors:
Vaghjimal, A
Rosenstreich, D
Hudes, G
Citation: A. Vaghjimal et al., Fever, rash and worsening of asthma in response to intravenous hydrocortisone, INT J CL PR, 53(7), 1999, pp. 567-568
Authors:
Hudes, G
Citation: G. Hudes, Signaling inhibitors in the clinic: New agents and new challenges, J CL ONCOL, 17(4), 1999, pp. 1093-1094
Authors:
Bubley, GJ
Carducci, M
Dahut, W
Dawson, N
Daliani, D
Eisenberger, M
Figg, WD
Freidlin, B
Halabi, S
Hudes, G
Hussain, M
Kaplan, R
Myers, C
Oh, W
Petrylak, DP
Reed, E
Roth, B
Sartor, O
Scher, H
Simons, J
Sinibaldi, V
Small, EJ
Smith, MR
Trump, DL
Vollmer, R
Wilding, G
Citation: Gj. Bubley et al., Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group, J CL ONCOL, 17(11), 1999, pp. 3461-3467
Authors:
Hudes, G
Einhorn, L
Ross, E
Balsham, A
Loehrer, P
Ramsey, H
Sprandio, J
Entmacher, M
Dugan, W
Ansari, R
Monaco, F
Hanna, M
Roth, B
Citation: G. Hudes et al., Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase network phase III trial, J CL ONCOL, 17(10), 1999, pp. 3160-3166
Risultati:
1-8
|